Reply to A. Indini et al

J Clin Oncol. 2016 Mar 20;34(9):1018-9. doi: 10.1200/JCO.2015.65.7007. Epub 2016 Jan 19.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antineoplastic Agents / adverse effects*
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Male
  • Melanoma / drug therapy*
  • Skin Neoplasms / drug therapy*

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Immunosuppressive Agents